(NEW YORK) -- American pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a booster dose of their bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of their original vaccine.According to a... Read More.
(NEW YORK) -- Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday.The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with... Read More.
(NEW YORK) -- After decades of researching respiratory syncytial virus, an illness especially dangerous for newborns and the elderly, scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year."Among very young children,... Read More.
(WASHINGTON) -- Pfizer's COVID-19 treatment Paxlovid has been hailed as a breakthrough in the fight against COVID-19. The pills have shown to dramatically reduce the risk of being hospitalized or dying for people who are at high-risk of COVID-19.But mounting evidence suggests Paxlovid may... Read More.
(NEW YORK) -- A panel of advisers at the Centers for Disease Control have greenlit the Pfizer and Moderna COVID-19 vaccines for kids as young as 6 months old, finding them both safe and effective.CDC Director Rochelle Walensky issued a recommendation for how doctors, nurses... Read More.
(WASHINGTON) -- The Food and Drug Administration has authorized the Pfizer and Moderna COVID-19 vaccines for kids as young as six months old, finding them both safe and effective."Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this... Read More.
(WASHINGTON) -- Parents with young kids are one step closer to getting them vaccinated following a grueling wait for the last remaining group to be authorized for a vaccine.The process for authorization and recommendation from the regulatory agencies kicked off Wednesday with a meeting... Read More.
(NEW YORK) -- Pfizer announced Wednesday that it has completed its application to the U.S. Food and Drug Administration for a three-dose COVID-19 vaccine in children aged 6 months to under 5 years old, and the federal agency has accepted the application."Pfizer and BioNTech... Read More.
(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
(NEW YORK) -- In the wake of the tragic milestone of 1 million official COVID-19 deaths in the United States, a new analysis found that without vaccines, the virus would have likely claimed more than 100,000 additional lives in 2021.The analysis, sponsored by Pfizer,... Read More.
(WASHINGTON) -- The head of the Food and Drug Administration on Thursday said the agency would move along to review Moderna’s data for its kid vaccine regardless of when Pfizer submits its data on kids under five, a move that will be welcome news... Read More.
(NEW YORK) -- By this fall, pharmaceutical giant Pfizer and its partner BioNTech could potentially have a COVID-19 booster that specifically addresses the omicron variant as well as its subvariants and other known strains of the virus, CEO Albert Bourla said during a panel... Read More.